MercadoLibre, Inc. (LON:0K0E)

Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,008	2,635	2,556	1,910	2,585	1,856
Short-Term Investments	965	1,051	1,191	1,120	208	604.36
Trading Asset Securities	10	9	-	-	-	-
Cash & Short-Term Investments	3,983	3,695	3,747	3,030	2,793	2,461
Cash Growth	-42.20%	-1.39%	23.66%	8.48%	13.50%	0.06%
Accounts Receivable	6,865	5,543	3,788	3,076	1,927	908.98
Other Receivables	-	216	140	195	212	84.1
Receivables	13,472	10,475	6,557	4,975	3,338	1,378
Inventory	434	296	238	152	253	118.14
Prepaid Expenses	-	46	27	38	40	28.38
Restricted Cash	3,880	2,064	1,292	1,453	1,063	651.83
Other Current Assets	4,293	3,566	2,399	1,305	688	709.6
Total Current Assets	26,062	20,142	14,260	10,953	8,175	5,347
Property, Plant & Equipment	3,463	2,478	2,149	1,649	1,268	694.9
Long-Term Investments	1,392	1,209	161	301	76	166.11
Goodwill	160	149	163	153	148	85.21
Other Intangible Assets	39	12	11	16	24	14.16
Long-Term Deferred Tax Assets	1,139	802	710	346	181	134.92
Other Long-Term Assets	416	225	93	286	168	67.62
Total Assets	32,948	25,196	17,612	13,736	10,101	6,526
Accounts Payable	6,431	5,119	3,189	1,876	1,373	765.73
Accrued Expenses	670	727	545	401	313	238.27
Short-Term Debt	8	26	33	19	148	509.01
Current Portion of Long-Term Debt	3,786	2,776	2,231	2,107	1,127	31.99
Current Portion of Leases	386	282	201	156	102	62.64
Current Income Taxes Payable	766	525	477	414	291	215.92
Current Unearned Revenue	97	77	51	44	34	32.52
Other Current Liabilities	9,606	7,071	4,536	3,545	2,449	1,780
Total Current Liabilities	21,750	16,603	11,263	8,562	5,837	3,636
Long-Term Debt	3,425	2,820	2,117	2,596	2,197	844.62
Long-Term Leases	1,405	975	768	551	408	259.86
Long-Term Deferred Tax Liabilities	293	204	183	106	62	64.35
Other Long-Term Liabilities	362	243	210	94	66	70.04
Total Liabilities	27,235	20,845	14,541	11,909	8,570	4,875
Common Stock	-	-	-	-	-	0.05
Additional Paid-In Capital	1,770	1,770	1,770	2,309	2,439	1,861
Retained Earnings	4,829	3,812	1,901	913	397	314.12
Treasury Stock	-311	-311	-310	-931	-790	-54.81
Comprehensive Income & Other	-575	-920	-290	-464	-515	-468.28
Total Common Equity	5,713	4,351	3,071	1,827	1,531	1,652
Shareholders' Equity	5,713	4,351	3,071	1,827	1,531	1,652
Total Liabilities & Equity	32,948	25,196	17,612	13,736	10,101	6,526
Total Debt	9,010	6,879	5,350	5,429	3,982	1,708
Net Cash (Debt)	-5,027	-3,184	-1,603	-2,399	-1,189	752.64
Net Cash Growth	-	-	-	-	-	-47.80%
Net Cash Per Share	-99.16	-62.80	-31.43	-46.73	-23.87	15.13
Filing Date Shares Outstanding	50.7	50.7	50.7	50.26	50.42	49.87
Total Common Shares Outstanding	50.7	50.7	50.7	50.26	50.42	49.87
Working Capital	4,312	3,539	2,997	2,391	2,338	1,711
Book Value Per Share	112.69	85.82	60.58	36.35	30.37	33.12
Tangible Book Value	5,514	4,190	2,897	1,658	1,359	1,552
Tangible Book Value Per Share	108.76	82.65	57.14	32.99	26.95	31.13
Land	-	74	83	118	141	96.97
Machinery	-	1,440	1,234	911	600	265.87
Construction In Progress	-	144	62	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.